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ideators and 8.72 ± 1.97 ng 5mC/µg DNA for non-ideators. There was no 
evidence of a significant difference between these two groups in our anal-
ysis (p=0.176). Also, we did not find a significant difference between global 
DNA methylation change (global DNA methylation change between base-
line and three-month follow-up visits) in patients with and without emer-
gent SI (p=0.121).
Discussion: This preliminary analysis did not find a predictive role of global 
DNA methylation in SI in patients with schizophrenia. The small sample 
size, used in this pilot study, is probably responsible for the fact that the 
results found here did not support those of previous research, showing that 
methylation levels are higher in patients with a history of a suicide attempt.
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Background: Neural correlates of psychotic disorders encompass multiple 
brain regions in multiple brain circuits, even at early stages. Previous re-
search has characterized structural brain alterations in first-episode psy-
chosis (FEP), but few studies have focused on the relationship between brain 
alterations and disease trajectories. First psychotic episodes typically evolve 
into a chronic course, affecting quality of life of patients and their families, 
with huge societal costs. Importantly, up to 80% of the patients relapse in 
the next five years after a first psychotic episode, with a significant risk of de-
veloping treatment resistance. Here, we investigated whether disease course 
may be predicted from brain structural assessments. Specifically, we meas-
ured structural covariance, a well-established approach to identify abnormal 
patterns of volumetric correlation across distant brain regions, which allows 
to incorporate network-level information to structural assessments. We 
performed a whole-brain structural covariance assessment of three bilateral 
regions form to three different cortical networks - dorsolateral prefrontal 
cortex (dlPFC) for the executive network, posterior cingulate cortex for the 
default mode network and insulae for the salience network - and subcortical 
structures (hippocampi, amygdalae and dorsomedial nucleus of the thal-
amus) that have shown to play a key role in schizophrenia.
Methods: We assessed a sample of 74 subjects from a multicenter, natu-
ralistic, prospective and longitudinal study designed to evaluate clin-
ical, neuropsychological, neuroimaging, biochemical, environmental and 
pharmacogenetic variables in first episode psychotic patients (PEPs project). 
Magnetic resonance imaging (MRI) scans were acquired at baseline and at 
2-year follow-up, as well as clinical assessments. Psychotic symptoms were 
assessed using the Positive and Negative Symptom Scale (PANSS) due its 
widespread use in clinical studies and its reliability in assessing psycho-
pathology across a range of patient populations. The sample was split in 
two groups as a function of the clinical improvement at 2-year follow-up: 
responders (i.e. 40% reduction in PANSS global score from baseline; n=29) 
and non-responders (n=45).
Results: Responder patients showed increase structural covariance between 
the left dlPFC and the left middle frontal gyrus, and between the right 
dlPFC and the right middle and superior gyrus, the left rectus and inferior 
frontal gyrus, the right hippocampus, and the vermis of the cerebellum. 
In addition, they showed increased structural covariance between the left 
anterior hippocampus and the ipsilateral middle occipital gyrus and the 
contralateral postcentral gyrus. Likewise, the structural covariance of right 
anterior hippocampus with right superior occipital gyrus and precentral 
gyrus was also increased in responder patients.
Discussion: This study shows, for the first time in the literature, that 
increased structural covariance at baseline within the executive network 
and between the hippocampi and posterior brain regions was associated 
with a superior treatment response at two-year follow-up. These results in-
dicate that the integrity of structural networks should be taken into ac-
count to predict treatment outcome in FEP patients.
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Background: Angiotensin I–converting enzyme (ACE) is a peptidase that 
converts angiotensin I into the vasoactive and aldosterone-stimulating pep-
tide angiotensin II, a key protein in controlling blood pressure. Recently, 
several evidences have shown a role of ACE in psychosis. However, the role 
of ACE in psychosis is poorly characterized, and at last unknown. In this 
study we hypothesized that ACE blood and CSF levels are lower in patients 
at first episode of psychosis (FEP) compared to controls; that blood ACE 
levels can predict the response to antipsychotics; that low plasma ACE 
levels correlate with both severity of symptoms and cognitive performance.
Methods: This research used data from a longitudinal cohort study of FEP 
(N = 138) and controls (N = 115). First of all, we conducted a two-group 
comparison analyses to assess the differences between patients and controls 
in terms of ACE levels in both blood and CSF. As a second step, we di-
vided our patients into treatment resistant (TR) and not treatment resistant 
t(non-TR) to investigate ACE blood levels in these two group. Finally, we 
evaluated the association between ACE blood levels and clinical phenotype 
and neurocognition.
Results: Two-group analyses showed lower levels of ACE in patients than 
controls, both in blood and CSF (p values< 0.05). The two-group analyses 
between TR and non-TR showed lower ACE blood levels in TRs compared 
to non-TRs (p value< 0.05). Finally, multiple regressions showed a contin-
uous relationship between cognitive performance and ACE blood levels (p 
values < 0.05).
Discussion: In conclusion, these findings showed that those FEP with lower 
ACE blood levels were not only more likely to develop TR conditions, but 
they also had greater cognitive impairment. These results are very prom-
ising, as they suggest that ACE levels can be used as a peripheral biomarker 
to stratify patients at first episode of psychosis.
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